Klink, Andrew J.
Kavati, Abhishek
Gassama, Awa T.
Kozlek, Tom
Gajra, Ajeet
Antoine, Ruth
Funding for this research was provided by:
Bayer Corporation
Article History
Accepted: 26 April 2022
First Online: 18 June 2022
Declarations
:
: This study was funded by Bayer.
: A.J.K. and A.G.: employees and owns stock in Cardinal Health. T.K.: employee and owns stock in Bayer USA. A.K., R.A., T.A.G.: employees of Bayer USA at the time of study conduct.
: This research study was conducted retrospectively from data obtained for clinical purposes. As described in Methods, prior to chart data abstraction, study materials (research protocol and eCRF) were submitted to an independent, central Institutional Review Board (Western Institutional Review Board [IRB]). The IRB determined that this study met the criteria for a waiver of authorization for use and disclosure of PHI and was exempt from IRB oversight. A waiver of informed consent was granted.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are not publicly available due to presence of protected health information (PHI).
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by all authors. The first draft of the manuscript was written by A.J.K. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.